Nanobiotix Appoints Dr. Bernd Muhlenweg as Head of Business Development

PARIS--(BUSINESS WIRE)--NANOBIOTIX the leading nanomedecine company focused on cancer therapy, announced today that its team has completed a comprehensive executive research and appointed Bernd Mühlenweg, PhD, as Head of Business Development.